Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS Meeting Abstract
| Authors: | Mansoor, W.; Arkenau, H. T.; Alsina, M.; Shitara, K.; Tejani, M. A.; Thuss-Patience, P. C.; Cuffe, S.; Dvorkin, M.; Park, D.; Ando, T.; Van Den Eynde, M.; Beretta, G. D.; Zaniboni, A.; Doi, T.; Tabernero, J.; Ilson, D. H.; Makris, L.; McGuigan, S.; Van Cutsem, E. |
| Abstract Title: | Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 231s |
| Language: | English |
| ACCESSION: | WOS:000487345805226 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.4038 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4038 -- Source: Wos |
